Sinopharm listing part of healthcare reform

    | BY

    clpstaff &clp articles

    Pharmaceutical and healthcare distributor Sinopharm Group closed its HK$8.73 billion (US$1.13 billion) global share offering on the HKEx on September 23.As…

    Pharmaceutical and healthcare distributor Sinopharm Group closed its HK$8.73 billion (US$1.13 billion) global share offering on the HKEx on September 23.

    As part of the offering, Sinopharm also entered into agreements with certain cornerstone investors to subscribe to up to US$195 million-worth of H-shares.

    This premium content is reserved for
    China Law & Practice Subscribers.

    • A database of over 3,000 essential documents including key PRC legislation translated into English
    • A choice of newsletters to alert you to changes affecting your business including sector specific updates
    • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
    For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]